Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877
- Status
- TERMINATED
- Phase
- PHASE1
Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Study of EZN-2968 Weekly in Adult Patients With Advanced Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment
- Status
- WITHDRAWN
- Phase
- PHASE1
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
- Status
- COMPLETED
- Phase
- NA
Alemtuzumab and Pentostatin In T-cell Neoplasms
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Actonel for the Prevention of Bone Loss
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only
- Status
- COMPLETED
- Phase
- PHASE2
R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP)
- Status
- TERMINATED
- Phase
- PHASE2
Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2